Michael Baumann went into radiation oncology because it has all the biological interest of medical oncology with added technical excitement. He claims the new targeted therapies will only come into their own when combined with radiotherapy, and last year he cofounded OncoRay, a state-of-the-art research facility, to help find out how this can best be done.
Leave a Reply